- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.80 Å
- Oligo State
- hetero-2-2-2-2-2-2-2-2-2-2-2-2-2-2-mer
- Ligands
- 2 x J6E: ~{N}-[4-fluoranyl-3-(3-morpholin-4-ylimidazo[1,2-a]pyrimidin-7-yl)phenyl]pyrrolidine-1-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wyllie, S. et al., Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition. Proc.Natl.Acad.Sci.USA (2019)
- Release Date
- 2019-04-17
- Peptides
- Proteasome alpha1 chain: AO
Proteasome alpha2 chain: BP
Proteasome alpha3 chain: CQ
Proteasome alpha4 chain: DR
Proteasome alpha5 chain: ES
Proteasome alpha6 chain: FT
Proteasome alpha7 chain: GU
Proteasome beta1 chain: HV
Proteasome beta2 chain: IW
Proteasome beta3 chain: JX
Proteasome beta4 chain: KY
Proteasome beta5 chain: LZ
Proteasome beta6 chain: M0
Proteasome beta7 chain: N1 - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AO
OB
BP
PC
CQ
QD
DR
RE
ES
SF
FT
TG
GU
UH
HV
VI
IW
WJ
JX
XK
KY
YL
LZ
ZM
M0
aN
N1
b